Skip to content
Open access · CC-BY via OpenAlex

Blood transcriptomic signatures for symptomatic tuberculosis in an African multicohort study

Vanessa Mwebaza Muwanga, Simon C. Mendelsohn, Vinzeigh Leukes, Kim Stanley, Stanley Kimbung Mbandi, Mzwandile Erasmus, Marika Flinn, Tarryn-Lee Fisher, Rodney Raphela, Nicole Bilek, Stephanus Theron Malherbe, Gerard Tromp, Gian D van der Spuy, Gerhard Walzl, Novel N. Chegou

European Respiratory Journal · 2024 · ▲ 33 citations

Abstract

Background Multiple host blood transcriptional signatures have been developed as non-sputum triage tests for tuberculosis (TB). We aimed to compare the diagnostic performance of 20 blood transcriptomic TB signatures for differentiating between symptomatic patients who have TBversusother respiratory diseases (ORD). Methods As part of a nested case–control study, individuals presenting with respiratory symptoms at primary healthcare clinics in Ethiopia, Malawi, Namibia, Uganda, South Africa and The Gambia were enrolled. TB was diagnosed based on clinical, microbiological and radiological findings. Transcriptomic signatures were measured in whole blood using microfluidic real-time quantitative PCR. Diagnostic performance was benchmarked against the World Health Organization Target Product Profile (TPP) for a non-sputum TB triage test. Results Among 579 participants, 158 had definite, microbiologically confirmed TB, 32 had probable TB, while 389 participants had ORD. Nine signatures differentiated between ORD and TB with equivalent performance (Satproedprai7: area under the curve 0.83 (95% CI 0.79–0.87); Jacobsen3: 0.83 (95% CI 0.79–0.86); Suliman2: 0.82 (95% CI 0.78–0.86); Roe1: 0.82 (95% CI 0.78–0.86); Kaforou22: 0.82 (95% CI 0.78–0.86); Sambarey10: 0.81 (95% CI 0.77–0.85); Duffy9: 0.81 (95% CI 0.76–0.86); Gliddon3: 0.8 (95% CI 0.75–0.85); Suliman4 0.79 (95% CI 0.75–0.84)). Benchmarked against a 90% sensitivity, these signatures achieved specificities between 44% (95% CI 38–49%) and 54% (95% CI 49–59%), not meeting the TPP criteria. Signature scores significantly varied by HIV status and country. In country-specific analyses, several signatures, such as Satproedprai7 and Penn-Nicholson6, met the minimal TPP criteria for a triage test in Ethiopia, Malawi and South Africa. Conclusion No signatures met the TPP criteria in a pooled analysis of all countries, but several signatures met the minimum criteria for a non-sputum TB triage test in some countries.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1183/13993003.00153-2024
Canonical
link ↗
Fetched
2026-11-16 MST

Cite this

APA
Muwanga, V.M., Mendelsohn, S.C., Leukes, V., Stanley, K., Mbandi, S.K., Erasmus, M., Flinn, M., Fisher, T., Raphela, R., Bilek, N., Malherbe, S.T., Tromp, G., Spuy, G.D.V.D., Walzl, G., Chegou, N.N., &amp; Scriba, T.J. (2024). Blood transcriptomic signatures for symptomatic tuberculosis in an African multicohort study. <em>European Respiratory Journal</em>. https://doi.org/10.1183/13993003.00153-2024
Vancouver
Muwanga VM, Mendelsohn SC, Leukes V, Stanley K, Mbandi SK, Erasmus M, et al. Blood transcriptomic signatures for symptomatic tuberculosis in an African multicohort study. European Respiratory Journal. 2024. doi:10.1183/13993003.00153-2024.
BibTeX
@article{vanessa2024Bloodt, title = {Blood transcriptomic signatures for symptomatic tuberculosis in an African multicohort study}, author = {Vanessa Mwebaza Muwanga and Simon C. Mendelsohn and Vinzeigh Leukes and Kim Stanley and Stanley Kimbung Mbandi and Mzwandile Erasmus and Marika Flinn and Tarryn-Lee Fisher and Rodney Raphela and Nicole Bilek and Stephanus Theron Malherbe and Gerard Tromp and Gian D van der Spuy and Gerhard Walzl and Novel N. Chegou and Thomas J. Scriba}, journal = {European Respiratory Journal}, year = {2024}, doi = {10.1183/13993003.00153-2024}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings